BRD4 and neoplasm: As expected, the pH/GSH‐responsiveness significantly facilitated the release of dBET6 from the nanoparticles within the cells, which led to the efficient degradation of BRD4, inducing apoptosis of both cell lines and the inhibition of tumor growth both in vitro and in vivo (Scheme 1).